Boxer Capital’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Boxer Capital’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,152,212	Closed	-$1.38M	–	64
2023 Q4	$1.38M	Hold	1,152,212	–	–	0.07%	46
2023 Q3	$993K	Hold	1,152,212	–	–	0.05%	64
2023 Q2	$1.38M	Sell	1,152,212 -995,000	-46%	-$4.98M	0.06%	71
2023 Q1	$18.8M	Hold	2,147,212	–	–	0.92%	34
2022 Q4	$17.2M	Buy	2,147,212 +972,212	+83%	+$6.1M	0.91%	37
2022 Q3	$5.73M	Hold	1,175,000	–	–	0.32%	50
2022 Q2	$6.53M	Hold	1,175,000	–	–	0.41%	45
2022 Q1	$5.96M	Hold	1,175,000	–	–	0.31%	50
2021 Q4	$15.1M	Hold	1,175,000	–	–	0.59%	37
2021 Q3	$17.6M	Hold	1,175,000	–	–	0.61%	47
2021 Q2	$18.3M	Buy	+1,175,000	New	+$20.6M	0.64%	50

Boxer Capital's RAIN Position: Q1 2024 in Review

Boxer Capital sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 1,152,212 shares — an estimated $1.38M sold.

Boxer Capital first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $18.8M in Q1 2023. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Boxer Capital reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Boxer Capital sold 1,152,212 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $1.38M.
Boxer Capital first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
Boxer Capital's Rain Oncology Inc. Common Stock position peaked at $18.8M in Q1 2023.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Boxer Capital's 13F filing for Q1 2024, filed 15 May 2024.